On April 20, 2026, a team of researchers from the Instituto de Salud Carlos III (ISCIII) in Spain announced the confirmation of a fresh species of parasite responsible for causing human babesiosis, marking a significant development in the understanding of this tick-borne disease. The discovery, detailed in a study published in the journal Emerging Microbes & Infections, identifies the parasite as Babesia hegotelforum, a species previously undocumented in human infections. This finding emerged from collaborative work between ISCIII’s National Microbiology Center and researchers at Yale University, who led the initial investigation.
Babesiosis is a malaria-like illness caused by Babesia parasites, which are transmitted to humans through the bite of infected ticks, primarily Ixodes scapularis in North America and Ixodes ricinus in Europe. Even as many infections are asymptomatic or mild, the disease can progress to severe complications including fever, hemolytic anemia, jaundice, and multi-organ failure, particularly in elderly individuals, those without a spleen, or people with weakened immune systems. Early diagnosis and treatment are critical, typically involving a combination of antiparasitic drugs such as atovaquone and azithromycin, or clindamycin and quinine in severe cases.
The identification of B. Hegotelforum was made possible through advanced genomic analysis and morphological characterization of parasite samples collected from patients presenting with unexplained febrile illness following tick exposure. According to the ISCIII-led study, the new species exhibits distinct genetic markers that differentiate it from other known Babesia species such as B. Microti and B. Divergens, which have historically been the primary causes of human babesiosis in the Americas and Europe, respectively. Microscopic examination revealed unique morphological traits in the parasite’s developmental stages, including variations in size and shape of the merozoites within infected red blood cells.
Dr. María Ángeles Risalde, a microbiologist at ISCIII and co-author of the study, emphasized the importance of the discovery in a statement released by the institute: “Confirming the existence of Babesia hegotelforum as a human pathogen expands our understanding of the diversity of Babesia species capable of infecting people and underscores the need for improved diagnostic tools that can distinguish between closely related parasites.” She noted that current diagnostic methods, which often rely on microscopy or PCR assays designed for known species, may fail to detect B. Hegotelforum without specific genetic targets.
A second study published alongside the species confirmation provided new genomic insights into Babesia divergens, the most common cause of human babesiosis in Europe. By comparing the genomes of B. Divergens strains from different geographic regions, researchers identified genetic adaptations linked to host immune evasion and transmission efficiency in ticks. These findings suggest that evolutionary pressures from both vertebrate hosts and tick vectors have shaped the parasite’s ability to establish infection in humans, offering potential targets for future interventions.
The zoonotic nature of babesiosis means that the parasite naturally circulates in wildlife reservoirs such as rodents and deer, with ticks acting as both vectors and maintenance hosts. Human infections occur when people enter tick-inhabited environments, particularly during warmer months when tick activity peaks. Public health officials in Spain and other European countries have reported a gradual increase in babesiosis cases over the past decade, possibly due to climate change expanding tick habitats, increased outdoor recreation, and greater awareness among clinicians.
In response to the growing concern over tick-borne diseases, the European Centre for Disease Prevention and Control (ECDC) has strengthened surveillance recommendations for babesiosis, urging member states to include the disease in national notification systems and to report cases systematically. While babesiosis is not currently notifiable at the EU level, several countries, including Germany and the Netherlands, have implemented voluntary reporting systems to monitor trends. In Spain, the Carlos III Health Institute continues to lead national efforts in pathogen detection and risk assessment for emerging zoonoses.
For individuals at risk, preventive measures focus on avoiding tick bites through the use of insect repellents containing DEET or picaridin, wearing protective clothing, and performing thorough tick checks after spending time in wooded or grassy areas. Prompt removal of attached ticks using fine-tipped tweezers can reduce the risk of pathogen transmission, as Babesia typically requires more than 24–36 hours of attachment to transmit effectively. Anyone who develops fever, fatigue, or anemia following a tick bite should seek medical evaluation, particularly if they have underlying health conditions that increase vulnerability to severe disease.
The discovery of B. Hegotelforum highlights the ongoing evolution of pathogens and the importance of sustained investment in microbiological research and zoonotic disease surveillance. As global temperatures rise and ecosystems shift, the geographic range of tick-borne illnesses is expected to expand, bringing new challenges for diagnosis, treatment, and prevention. Continued collaboration between human health, veterinary, and environmental sectors—under the One Health framework—will be essential to anticipate and respond to emerging threats like novel Babesia species.
As of now, no specific treatments or vaccines target B. Hegotelforum, and clinical management remains based on extrapolated guidelines from related Babesia species. Researchers at ISCIII and their international partners are calling for further studies to determine the parasite’s geographic distribution, reservoir hosts, and antigenic profile, which will inform the development of specific diagnostic tests and potential therapeutic strategies. The full genomic sequence of B. Hegotelforum has been deposited in public databases to support global research efforts.
Moving forward, the scientific community awaits additional epidemiological data to assess the public health impact of B. Hegotelforum infections. The next scheduled update from the ISCIII team is expected later in 2026, when they plan to present findings from ongoing surveillance studies at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Until then, health authorities recommend maintaining vigilance for tick-borne illnesses and adhering to established prevention practices.
Stay informed about emerging infectious diseases and public health developments by following trusted sources such as the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), and national health institutes. Share this article to help raise awareness about babesiosis and the importance of tick bite prevention.